-
Current guidelines recommend hypothermia for comatose survivors of out-of-hospital cardiac arrest in whom return of circulation has been achieved.
-
Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
-
This paper provides up-to-date information on the incidence of sudden cardiac death in athletes at National Collegiate Athletic Association (NCAA) institutions.
-
In this paper, Singh and his colleagues from the MADIT-CRT study looked at the influence of left ventricular lead position on responses to therapy in that trial. MADIT-CRT was a randomized clinical trial of patients with indications for an ICD New York Heart Association (NYHA) class I or II heart failure and a QRS duration > 130 msec.
-
The utility of inflammatory markers in acute pericarditis is not well understood. Thus, these investigators from Italy prospectively evaluated serial high sensitivity C-reactive protein (hs-CRP) serum levels in patients with acute pericarditis followed for 24 months on average.
-
-
The source of embolic thrombotic material in patients with cryptogenic stroke is controversial.
-
The heartmate ii left ventricular assist device (LVAD) is a continuous flow device compared to the pulsatile flow Heartmate I.
-
The madit-crt trial compared the effects of implanting defibrillators with and without resynchronization therapy in patients with New York Heart Association (NYHA) functional class I and II heart failure symptoms,
-
Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
